Pamidronate Disodium 30 MG Injection

Known as: PAMIDRONATE DISODIUM 3 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, PAMIDRONATE DISODIUM 30MG/VIL INJ [VA Product], PAMIDRONATE DISODIUM 30MG/VIL INJ

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2016

Bone targeted treatments in cancer – The story so far

R. Coleman
Journal of bone oncology
2016
Corpus ID: 5522911

2008

Vδ2 T‐lymphocyte responses in cord blood samples from Italy and Côte d’Ivoire

C. Cairo, G. Mancino, V. Colizzi
Immunology
2008
Corpus ID: 22544844

Cord blood T lymphocytes are immature and their functional defect partially reflects a suboptimal level of costimulatory signals…

2005

PCN5 BUDGET IMPACT ANALYSIS OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. ORAL IBANDRONATE OR IV GENERIC PAMIDRONATE IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES…

M. Botteman, M. Aapro, J. Stephens, J. Hay, J. Brandman
2005
Corpus ID: 71173904

1997

P930. Supportive care with disodic pamidronate in the treatment of breast cancer metastatic bone lesions

P. Candido, M. Cattaneo, E. Piazza
1997
Corpus ID: 71610065

Pamidronate Disodium 30 MG Injection

Related topics

Broader (1)

Papers overview